Estrogen and progesterone play pivotal roles in endothelial progenitor cell proliferation

Reproductive Biology and Endocrinology

Research

Yuko Matsubara¹  Keiichi Matsubara¹ 

[1] Department of Obstetrics and Gynecology, Ehime Prefectural Niihama Hospital,Hongo, 792-0042, Niihama, Ehime, Japan;

关键词: menstrual cycle;    neovascularization;    ovarian hormones;   

DOI  :  10.1186/1477-7827-10-2

 received in 2011-09-07, accepted in 2012-01-17,  发布年份 2012

来源: Springer

【 摘 要 】

BackgroundIt has been previously suggested that angiogenesis occurs during the menstrual cycle. Moreover, a rise in uterine blood flow is largely maintained by vasodilatation and substantial increases in angiogenesis. It is known that estradiol (E2) and progesterone (P4) are involved in angiogenesis. Recently, endothelial progenitor cells (EPCs) were found to be involved in neovascularization; however, their roles in uterine neovascularization have not been well characterized. We hypothesized that E2- or P4-mediated EPC proliferation plays important roles in uterine neovascularization during the menstrual cycle.MethodsThe number of EPCs in peripheral blood from subjects in the menstrual phase (n = 12), follicular phase (n = 8), and luteal phase (n = 16), was measured using flow cytometry. Peripheral blood mononuclear cells (PBMCs) were cultured for seven days with or without 17beta-estradiol (E2beta) or P4, followed by assessment of EPC proliferation based upon the uptake of acetylated low density lipoprotein (LDL) and lectin. The expression of estrogen receptor (ER) or progesterone receptor (PR) in EPCs was also evaluated using real-time PCR.ResultsE2beta and P4 significantly increased the proliferation of EPCs derived from the peripheral blood of subjects in menstrual phase, but not subjects in the luteal phase. In addition, the expression level of ERalpha was markedly higher than ERbeta in EPCs derived from women in menstrual phase.ConclusionsEPC proliferation is induced during the menstrual phase and proliferation can be affected by estrogen through ERalpha activation.

【 授权许可】

CC BY   
© Matsubara and Matsubara; licensee BioMed Central Ltd. 2012